Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $155,998,007 | $157,025,752 | $115,131,340 | $118,371,593 |
| - Cash | $25,169,000 | $22,894,000 | $367,950 | $246,557 |
| + Debt | $1,280,000 | $1,340,000 | $1,490,000 | $1,640,000 |
| Enterprise Value | $132,109,007 | $135,471,752 | $116,253,390 | $119,765,036 |
| Revenue | $88,330,000 | $75,579,000 | $67,493,000 | $65,381,000 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | $44,065,000 | $37,341,000 | $223,559 | $238,408 |
| % Margin | 49.9% | 49.4% | 0.3% | 0.4% |
| EBITDA | $20,246,000 | $18,721,000 | $2,966,000 | $2,328,000 |
| % Margin | 22.9% | 24.8% | 4.4% | 3.6% |
| Net Income | $11,961,000 | $11,160,000 | $10,528,000 | $12,921,000 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.21 | 246.58 | 228.31 | 280.2 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | $6,521,000 | -$1,677,000 | -$50,273 | $12,594 |
| Capital Expenditures | -$5,030,000 | -$1,833,000 | -$54,458 | -$46,998 |
| Free Cash Flow | $1,491,000 | -$3,510,000 | -$104,731 | -$34,404 |